Skip to content

Investigating Proximal Muscle Strength Effects by Incorporating Proximal Muscle Lengthening

Investigating Proximal Muscle Strength Effects by Incorporating Proximal Muscle Lengthening

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05710757
Enrollment
60
Registered
2023-02-02
Start date
2023-10-16
Completion date
2024-09-30
Last updated
2024-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Proximal Muscle Lengthening, Proximal Muscle Strength

Keywords

blood flow restriction, myofascial release

Brief summary

The purpose of this study is to assess strength gains of proximal musculature in the nondominant upper extremity after implementing blood flow restriction (BFR) and myofascial release (MFR) with the supplementation of whey protein.

Detailed description

The purpose of this study is to assess strength gains of proximal musculature in the nondominant upper extremity after implementing blood flow restriction (BFR) and myofascial release (MFR) with the supplementation of whey protein. Blood flow restricted (BFR) exercise is the brief and non-continuous blockage of venous blood flow using a device that restricts the flow of blood while exercising. This technique is used to produce hypertrophy (muscle growth) and strength responses while exercising at a lighter load than traditionally required to produce a similar response. Myofascial release (MFR) is a technique that involves applying gentle sustained pressure into the myofascial connective tissue restrictions to eliminate pain and restore motion.

Interventions

OTHERmyofascial release

Myofascial release (MFR) is a technique that involves applying gentle sustained pressure into the myofascial connective tissue restrictions to eliminate pain and restore motion.

DEVICEblood flow restriction

Blood flow restricted (BFR) exercise is the brief and non-continuous blockage of venous blood flow using a device that restricts the flow of blood while exercising. This technique is used to produce hypertrophy (muscle growth) and strength responses while exercising at a lighter load than traditionally required to produce a similar response.

Sponsors

University of Tennessee
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

The control group will receive a sham intervention.

Intervention model description

The control group will receive a sham myofascial release pectoralis minor release intervention. The experimental group will receive a myofascial release pectoralis minor release intervention. Both groups will receive blood flow restriction exercise to strength the scapula retractors.

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy individuals between the age of 18 and 30

Exclusion criteria

* Individuals with uncontrolled high blood pressure * Individuals with sickle cell anemia, current pregnancy * Individuals with a history of deep vein thrombosis * Individuals with diabetes * Individuals with active infection * Individuals with less than normal range of motion or muscle strength * Individuals with moderate to severe upper extremity injury in the past 12 months * Individuals with a current diagnosis of cancer.

Design outcomes

Primary

MeasureTime frameDescription
Scapular retraction strength8 weeksAssess scapular retraction strength with a dynamometer

Secondary

MeasureTime frameDescription
One repetition maximum (1RM)8 weeksmaximum amount of weight that can be lifted one time for scapular retractors on a row machine

Other

MeasureTime frameDescription
Length for the pectoralis minor8 weeksAssess length of the pectoralis minor with a tape measure

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026